Regression-based Deep-Learning predicts molecular biomarkers from pathology slides

• URL: http://arxiv.org/abs/2304.05153v1
• Date: Tue, 11 Apr 2023 11:43:51 GMT
• Title: Regression-based Deep-Learning predicts molecular biomarkers from pathology slides
• Authors: Omar S. M. El Nahhas, Chiara M. L. Loeffler, Zunamys I. Carrero, Marko van Treeck, Fiona R. Kolbinger, Katherine J. Hewitt, Hannah S. Muti, Mara Graziani, Qinghe Zeng, Julien Calderaro, Nadina Ortiz-Br\"uchle, Tanwei Yuan, Michael Hoffmeister, Hermann Brenner, Alexander Brobeil, Jorge S. Reis-Filho, Jakob Nikolas Kather
• Abstract summary: We developed and evaluated a new self-supervised attention-based weakly supervised regression method that predicts continuous biomarkers directly from images. Using regression significantly enhances the accuracy of biomarker prediction, while also improving the interpretability of the results over classification. Our open-source regression approach offers a promising alternative for continuous biomarker analysis in computational pathology.
• Score: 40.24757332810004
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Deep Learning (DL) can predict biomarkers from cancer histopathology. Several clinically approved applications use this technology. Most approaches, however, predict categorical labels, whereas biomarkers are often continuous measurements. We hypothesized that regression-based DL outperforms classification-based DL. Therefore, we developed and evaluated a new self-supervised attention-based weakly supervised regression method that predicts continuous biomarkers directly from images in 11,671 patients across nine cancer types. We tested our method for multiple clinically and biologically relevant biomarkers: homologous repair deficiency (HRD) score, a clinically used pan-cancer biomarker, as well as markers of key biological processes in the tumor microenvironment. Using regression significantly enhances the accuracy of biomarker prediction, while also improving the interpretability of the results over classification. In a large cohort of colorectal cancer patients, regression-based prediction scores provide a higher prognostic value than classification-based scores. Our open-source regression approach offers a promising alternative for continuous biomarker analysis in computational pathology.

Related papers

• Screen Them All: High-Throughput Pan-Cancer Genetic and Phenotypic Biomarker Screening from H&E Whole Slide Images [3.119559770601732]
  Using AI on routine H&E slides offers a fast and economical approach to screen for multiple molecular biomarkers. We present a high- throughput AI-based system leveraging Virchow2, a foundation model pre-trained on 3 million slides. Unlike traditional methods that train individual models for each biomarker or cancer type, our system employs a unified model to simultaneously predict a wide range of clinically relevant molecular biomarkers.
  arXiv  Detail & Related papers  (2024-08-18T17:44:00Z)
• Biomarker based Cancer Classification using an Ensemble with Pre-trained Models [2.2436844508175224]
  We propose a novel ensemble model combining pre-trained Hyperfast model, XGBoost, and LightGBM for multi-class classification tasks. We leverage a meta-trained Hyperfast model for classifying cancer, accomplishing the highest AUC of 0.9929. We also propose a novel ensemble model combining pre-trained Hyperfast model, XGBoost, and LightGBM for multi-class classification tasks, achieving an incremental increase in accuracy (0.9464)
  arXiv  Detail & Related papers  (2024-06-14T14:43:59Z)
• Machine Learning Driven Biomarker Selection for Medical Diagnosis [1.10252115875756]
  Recent advances in experimental methods have enabled researchers to collect data on thousands of analytes simultaneously. This has led to correlational studies that associated molecular measurements with diseases such as Alzheimer's, Liver, and Gastric Cancer. The use of thousands of biomarkers selected from the analytes is not practical for real-world medical diagnosis and is likely undesirable due to potentially formed spurious correlations.
  arXiv  Detail & Related papers  (2024-05-16T01:30:47Z)
• Deep Learning Predicts Biomarker Status and Discovers Related Histomorphology Characteristics for Low-Grade Glioma [21.281553456323998]
  Biomarker detection is an indispensable part in the diagnosis and treatment of low-grade glioma (LGG) We propose an interpretable deep learning pipeline to predict the status of five biomarkers in LGG using only hematoxylin and eosin-stained whole slide images and slide-level biomarker status labels. Our pipeline not only provides a novel approach for biomarker prediction, enhancing the applicability of molecular treatments for LGG patients but also facilitates the discovery of new mechanisms in molecular functionality and LGG progression.
  arXiv  Detail & Related papers  (2023-10-11T13:05:33Z)
• A marker-less human motion analysis system for motion-based biomarker discovery in knee disorders [60.99112047564336]
  The NHS has been having increased difficulty seeing all low-risk patients, this includes but not limited to suspected osteoarthritis (OA) patients. We propose a novel method of automated biomarker identification for diagnosis of knee disorders and the monitoring of treatment progression.
  arXiv  Detail & Related papers  (2023-04-26T16:47:42Z)
• Open-Set Recognition of Breast Cancer Treatments [91.3247063132127]
  Open-set recognition generalizes a classification task by classifying test samples as one of the known classes from training or "unknown" We apply a recent existing Gaussian mixture variational autoencoder model, which achieves state-of-the-art results for image datasets, to breast cancer patient data. Not only do we obtain more accurate and robust classification results, with a 24.5% average F1 increase compared to a recent method, but we also reexamine open-set recognition in terms of deployability to a clinical setting.
  arXiv  Detail & Related papers  (2022-01-09T04:35:55Z)
• Lung Cancer Lesion Detection in Histopathology Images Using Graph-Based Sparse PCA Network [93.22587316229954]
  We propose a graph-based sparse principal component analysis (GS-PCA) network, for automated detection of cancerous lesions on histological lung slides stained by hematoxylin and eosin (H&E) We evaluate the performance of the proposed algorithm on H&E slides obtained from an SVM K-rasG12D lung cancer mouse model using precision/recall rates, F-score, Tanimoto coefficient, and area under the curve (AUC) of the receiver operator characteristic (ROC)
  arXiv  Detail & Related papers  (2021-10-27T19:28:36Z)
• The Future will be Different than Today: Model Evaluation Considerations when Developing Translational Clinical Biomarker [4.549866091318765]
  We present one evaluation strategy by using leave-one-study-out (LOSO) in place of conventional cross-validation (cv) methods. To demonstrate the performance of K-fold vs LOSO cv in estimating the effect size of biomarkers, we leveraged data from clinical trials and simulation studies.
  arXiv  Detail & Related papers  (2021-07-13T19:36:25Z)
• Cancer Gene Profiling through Unsupervised Discovery [49.28556294619424]
  We introduce a novel, automatic and unsupervised framework to discover low-dimensional gene biomarkers. Our method is based on the LP-Stability algorithm, a high dimensional center-based unsupervised clustering algorithm. Our signature reports promising results on distinguishing immune inflammatory and immune desert tumors.
  arXiv  Detail & Related papers  (2021-02-11T09:04:45Z)
• G-MIND: An End-to-End Multimodal Imaging-Genetics Framework for Biomarker Identification and Disease Classification [49.53651166356737]
  We propose a novel deep neural network architecture to integrate imaging and genetics data, as guided by diagnosis, that provides interpretable biomarkers. We have evaluated our model on a population study of schizophrenia that includes two functional MRI (fMRI) paradigms and Single Nucleotide Polymorphism (SNP) data.
  arXiv  Detail & Related papers  (2021-01-27T19:28:04Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.